GOOG vs PFE: Which Is the Better Buy?
Side-by-side comparison of Alphabet Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-18.
Alphabet Inc. · Communication Services
$339.40
-4.4% upside to fair value
Grade D
High Quality
VS
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
PFE has more upside to fair value
(+30.1%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GOOG |
PFE |
| Current Price |
$339.40 |
$26.91 |
| Fair Value Estimate |
$324.34 |
$35.00 |
| Upside to Fair Value |
-4.4%
|
+30.1%
|
| Market Cap |
$4,105.7B |
$153.0B |
| Forward P/E |
31.2x
|
9.5x
|
| EV / EBITDA |
23.1x
|
13.8x
|
| Price / Sales |
10.3x
|
2.4x
|
| Price / FCF |
56.4x
|
16.8x
|
| Revenue Growth YoY |
+11.3%
|
-1.6%
|
| Gross Margin |
59.7%
|
70.3%
|
| Operating Margin |
32.0%
|
24.7%
|
| Return on Equity |
35.0%
|
9.0%
|
| Dividend Yield |
0% |
6.4% |
| FCF Yield |
1.77%
|
5.9%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Alphabet Inc. operates as a global leader in internet content, advertising, cloud computing, and AI technologies, with dominant market positions in search, browser, and mobile operating systems. The company benefits from a high-quality business model characterized by a durable competitive moat, strong revenue growth of 11.3% year-over-year, and robust profitability with net margins of 32.8%. Desp…
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Accumulation Zones
| Metric |
GOOG |
PFE |
| Zone Low |
$243.25 |
$25.00 |
| Zone High |
$275.69 |
$29.00 |
| In Buy Zone? |
No
|
Yes
|